Related references
Note: Only part of the references are listed.High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis
Yongyin Gao et al.
BMC CANCER (2023)
CXCR4 promotes the growth and metastasis of esophageal squamous cell carcinoma as a critical downstream mediator of HIF-1 alpha
Xianxian Wu et al.
CANCER SCIENCE (2022)
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
Ying Zhou et al.
NUCLEIC ACIDS RESEARCH (2022)
USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1
Tanuza Das et al.
CELL DEATH DISCOVERY (2022)
USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction
Mi-Jeong Kim et al.
CELL DEATH & DISEASE (2022)
LOXL3-promoted hepatocellular carcinoma progression via promotion of Snail1/USP4-mediated epithelial-mesenchymal transition
Rong Li et al.
ENVIRONMENTAL TOXICOLOGY (2022)
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020
Eileen Morgan et al.
GASTROENTEROLOGY (2022)
Transcriptome Analysis and Single-Cell Sequencing Analysis Constructed the Ubiquitination-Related Signature in Glioma and Identified USP4 as a Novel Biomarker
Qikai Tang et al.
FRONTIERS IN IMMUNOLOGY (2022)
WNT5A promotes the metastasis of esophageal squamous cell carcinoma by activating the HDAC7/SNAIL signaling pathway
Yingtong Feng et al.
CELL DEATH & DISEASE (2022)
SOX2-Upregulated microRNA-30e Promotes the Progression of Esophageal Cancer via Regulation of the USP4/SMAD4/CK2 AxisS
Yang Yang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)
Chengqiang Li et al.
EUROPEAN JOURNAL OF CANCER (2021)
Advances and challenges in the treatment of esophageal cancer
Shiming He et al.
ACTA PHARMACEUTICA SINICA B (2021)
Spotlight on USP4: Structure, Function, and Regulation
Binbin Hu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
High-mobility group AT-hook 2 promotes growth and metastasis and is regulated by miR-204-5p in oesophageal squamous cell carcinoma
Hongdian Zhang et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma The NEOCRTEC5010 Randomized Clinical Trial
Hong Yang et al.
JAMA SURGERY (2021)
Epigenetic Silencing of Ubiquitin Specific Protease 4 by Snail1 Contributes to Macrophage-Dependent Inflammation and Therapeutic Resistance in Lung Cancer
Chao-Yang Lai et al.
CANCERS (2020)
Resistance to FGFR1-targeted therapy leads to autophagy via TAK1/AMPK activation in gastric cancer
Rui Peng et al.
GASTRIC CANCER (2020)
USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target
Yizhi Wang et al.
CANCER CELL INTERNATIONAL (2020)
The Deubiquitinase USP4 Stabilizes Twist1 Protein to Promote Lung Cancer Cell Stemness
Fengtian Li et al.
CANCERS (2020)
Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic cancer
Yizhi Wang et al.
EXPERIMENTAL CELL RESEARCH (2020)
Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options
Xiaowei Wu et al.
CELL DEATH & DISEASE (2020)
The Roles of Ubiquitin-Binding Protein Shuttles in the Degradative Fate of Ubiquitinated Proteins in the Ubiquitin-Proteasome System and Autophagy
Katarzyna Zientara-Rytter et al.
CELLS (2019)
Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination
Tianyi Li et al.
CELL DEATH & DISEASE (2018)
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy
Raffaela Santoro et al.
DRUG RESISTANCE UPDATES (2017)
Ubiquitin-specific protease 4 improves the prognosis of the patients in esophageal cancer
Rong Yao et al.
CANCER BIOMARKERS (2017)
USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2
Z. Li et al.
ONCOGENE (2016)
MicroRNA-215 suppresses cell proliferation, migration and invasion of colon cancer by repressing Yin Yang 1
Zehong Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
G. Piro et al.
BRITISH JOURNAL OF CANCER (2015)
Ubiquitin-specific protease 4 promotes TNF-α-induced apoptosis by deubiquitination of RIP1 in head and neck squamous cell carcinoma
Xiaozhi Hou et al.
FEBS LETTERS (2013)
Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration
Ning Xiao et al.
BIOCHEMICAL JOURNAL (2012)
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor
Long Zhang et al.
NATURE CELL BIOLOGY (2012)
USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation
Y-H Fan et al.
CELL DEATH AND DIFFERENTIATION (2011)